{
  "ptid_time": "135_S_4689_2012-07-27",
  "img_path": "/data/qiuhui/data/adni/images/135_S_4689/2012-07-27/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 27,062 mm³, 9.9% below the reference mean. With a Z-score of -0.23 (40.7th percentile), this represents normal volume ; hippocampal volume measures 5,416 mm³, 32.5% below the reference mean. With a Z-score of -3.25 (0.1th percentile), this represents profound atrophy; whole brain volume measures 911,808 mm³, 19.6% below the reference mean. With a Z-score of -2.78 (0.3th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,058 mm³, 51.7% below the reference mean. With a Z-score of -3.58 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 17,254 mm³, 13.3% below the reference mean. With a Z-score of -1.11 (13.4th percentile), this represents mild atrophy; middle temporal gyrus volume measures 17,555 mm³, 21.7% below the reference mean. With a Z-score of -1.78 (3.7th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 69.6 years. Gender is Male. Education: 16 years. Handedness: Left. Race: White. Medical history: Psychiatric; Cardiovascular; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary. MMSE: 29.0. MoCA: 24.0. Logical Memory: 5.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.50 SUVR (profound elevated); Amyloid beta: 747.30 pg/mL (normal ); Total tau: 384.70 pg/mL (moderate elevated); Phosphorylated tau: 32.40 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows profound atrophy in the hippocampus and entorhinal cortex, along with significant whole brain atrophy—key regions affected in Alzheimer's disease. Despite normal Aβ levels, elevated AV45 (amyloid PET) suggests amyloid pathology, while elevated T-tau and P-tau indicate neurodegeneration. The MoCA score (24/30) suggests mild cognitive impairment, while the MMSE (29/30) is less sensitive.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease** (biomarker-supported).  \n\n**Confidence:** **High** (due to clear structural atrophy, tau elevation, and amyloid positivity despite normal CSF Aβ).",
  "timestamp": "2025-07-26T15:41:34.407310"
}